NCT06272162View on ClinicalTrials.gov

Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions
Locally Advanced Pancreatic Adenocarcinoma
Interventions
RADIATION

MR guided radiotherapy

5 fractions of 10 Gray MRgRT in addition to standard of care

Trial Locations (4)

5623 EJ

Catharina Hospital, Eindhoven

1081 HV

Amsterdam University Medical Center, VUmc, Amsterdam

6525 GA

Radboud University Medical Center, Nijmegen

3584CX

University Medical Center Utrecht, Utrecht

All Listed Sponsors
collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

Catharina Ziekenhuis Eindhoven

OTHER

collaborator

Centre for Human Drug Research, Netherlands

OTHER

collaborator

Dutch Pancreatic Cancer Group (DPCG)

UNKNOWN

lead

UMC Utrecht

OTHER